Jean Marie Duvall is an accomplished leader in the pharmaceutical industry. Over a 14-year tenure as one of four Executive Board members with Ferring Pharmaceuticals, she significantly contributed to tripling the company’s revenue and solidifying its position in Reproductive Medicine and Maternal Health.

Beyond Ferring, Jean Marie co-founded and chaired two biotech ventures: Trizell, an oncology gene and cell therapy start-up that raised $570 million and advanced through phase 2 and 3 clinical trials, and Amzell, a company focusing on life-cycle management for the U.S. market, with two products successfully moving through phase 2 trials.